Analysis of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals

Bowel Disorders Market is Buoyant and Poised for Growth

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

This research service is focused on the major bowel disorders and evaluates the market for oral and injectable prescription pharmaceuticals for the treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). This research service covers the U.S. market from 2009 to 2017, with 2011 as the base year. Included are products on the market, products in development, as well as patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. Disease-specific topics including definitions, diagnosis, disease assessment, and clinical treatment guidelines are also outlined and discussed.

Table of Contents

Analysis of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals , The U.S. Bowel Disorders Prescription Pharmaceuticals MarketAnalysis of the Bowel Disorders Prescription Pharmaceuticals Market in the U.S.Executive Summary and Market OverviewAnalysis of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals , Bowel Disorders Prescription Pharmaceuticals Market - Total MarketAnalysis of the Total Bowel Disorders Prescription Pharmaceuticals MarketDrivers and RestraintsForecast and TrendsDemand AnalysisMarket Share and Competitive AnalysisAnalysis of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals , Inflammatory Bowel Disease Prescription Pharmaceuticals SegmentAnalysis of the Inflammatory Bowel Disease Prescription Pharmaceuticals SegmentSegment Breakdown and Market Engineering MeasurementsAnalysis of the 5-ASA Subsegment of the Inflammatory Bowel Disease Prescription Pharmaceuticals SegmentSubsegment Breakdown and Market Engineering MeasurementsTreated Patient ForecastPricing Trends and ForecastRevenue ForecastMarket Share Analysis Analysis of the Corticosteroid Subsegment of the Inflammatory Bowel Disease Prescription Pharmaceuticals SegmentSubsegment Breakdown and Market Engineering MeasurementsTreated Patient ForecastPricing Trends and ForecastRevenue ForecastMarket Share Analysis Analysis of the TNF Inhibitor Subsegment of the Inflammatory Bowel Disease Prescription Pharmaceuticals SegmentSubsegment Breakdown and Market Engineering MeasurementsTreated Patient ForecastPricing Trends and ForecastRevenue ForecastMarket Share Analysis Analysis of the Non-TNF Biologicals Subsegment of the Inflammatory Bowel Disease Prescription Pharmaceuticals SegmentSubsegment Breakdown and Market Engineering MeasurementsTreated Patient ForecastPricing Trends and ForecastRevenue ForecastAnalysis of the Novel Orals Subsegment of the Inflammatory Bowel Disease Prescription Pharmaceuticals SegmentSubsegment Breakdown and Market Engineering MeasurementsTreated Patient ForecastPricing Trends and ForecastRevenue ForecastAnalysis of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals , Irritable Bowel Syndrome Prescription Pharmaceuticals Segment Analysis of the Irritable Bowel Syndrome Prescription Pharmaceuticals SegmentSegment Breakdown and Market Engineering MeasurementsPatient ForecastPricing Trends and ForecastRevenue ForecastAnalysis of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals , Summary and Conclusions Summary and Conclusions The Last WordGame-changing StrategiesAnalysis of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals , AppendixAppendixAppendix




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Nov-17

Region : North America

Release Date : 15-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.